These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 30993818)

  • 1. Optimising psychotropic medication prescribing to reduce adverse drug events.
    Strydom A; Melville C
    J Intellect Disabil Res; 2019 May; 63(5):369-371. PubMed ID: 30993818
    [No Abstract]   [Full Text] [Related]  

  • 2. Structured Medication Review to Improve Pharmacotherapy in People with Intellectual Disability and Behavioural Problems.
    Scheifes A; Egberts TC; Stolker JJ; Nijman HL; Heerdink ER
    J Appl Res Intellect Disabil; 2016 Jul; 29(4):346-55. PubMed ID: 25882186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Problem behaviours and psychotropic medication use in intellectual disability: a multinational cross-sectional survey.
    Perry BI; Cooray SE; Mendis J; Purandare K; Wijeratne A; Manjubhashini S; Dasari M; Esan F; Gunaratna I; Naseem RA; Hoare S; Chester V; Roy A; Devapriam J; Alexander R; Kwok HF
    J Intellect Disabil Res; 2018 Feb; 62(2):140-149. PubMed ID: 29349928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse events and the relation with quality of life in adults with intellectual disability and challenging behaviour using psychotropic drugs.
    Scheifes A; Walraven S; Stolker JJ; Nijman HL; Egberts TC; Heerdink ER
    Res Dev Disabil; 2016; 49-50():13-21. PubMed ID: 26647003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antipsychotics in the management of behavioral and psychological symptoms of dementia: maximizing gain and minimizing harm.
    Tampi RR; Tampi DJ; Rogers K; Alagarsamy S
    Neurodegener Dis Manag; 2020 Feb; 10(1):5-8. PubMed ID: 32027552
    [No Abstract]   [Full Text] [Related]  

  • 6. [Practical guidelines for prescribing psychotropic medication to people with intellectual disability].
    de Kuijper G; Degraeve G; Zinkstok JR
    Tijdschr Psychiatr; 2019; 61(11):786-791. PubMed ID: 31907889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and patterns of anti-epileptic medication prescribing in the treatment of epilepsy in older adults with intellectual disabilities.
    O'Dwyer M; Peklar J; Mulryan N; McCallion P; McCarron M; Henman MC
    J Intellect Disabil Res; 2018 Mar; 62(3):245-261. PubMed ID: 29314463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychotropic prescribing in people with intellectual disability and challenging behaviour.
    Sheehan R; Strydom A; Morant N; Pappa E; Hassiotis A
    BMJ; 2017 Aug; 358():j3896. PubMed ID: 28821479
    [No Abstract]   [Full Text] [Related]  

  • 9. Quality of prescribing of antipsychotic medication for people with intellectual disability under the care of UK mental health services: a cross-sectional audit of clinical practice.
    Paton C; Bhatti S; Purandare K; Roy A; Barnes T
    BMJ Open; 2016 Dec; 6(12):e013116. PubMed ID: 27920085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychotropic medication use in adults with intellectual disability in Queensland, Australia, from 1999 to 2015: a cohort study.
    Song M; Ware R; Doan TN; Harley D
    J Intellect Disabil Res; 2020 Jan; 64(1):45-56. PubMed ID: 31478300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AAPL Practice Resource for Prescribing in Corrections.
    J Am Acad Psychiatry Law; 2018 Jun; 46(2 Supplement):S2-S50. PubMed ID: 29884616
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of psychotropic medication in people with a learning disability.
    Jenkins R
    Br J Nurs; 2000 Jul 13-26; 9(13):844-50. PubMed ID: 11261057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unnecessary psychotropic drug prescription in primary care for people with intellectual disability.
    Trollor J; Salomon C
    Evid Based Ment Health; 2016 May; 19(2):62. PubMed ID: 27075445
    [No Abstract]   [Full Text] [Related]  

  • 14. Psychotropic prescribing for persons with intellectual disabilities and other psychiatric disorders.
    Edelsohn GA; Schuster JM; Castelnovo K; Terhorst L; Parthasarathy M
    Psychiatr Serv; 2014 Feb; 65(2):201-7. PubMed ID: 24233105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving knowledge of psychotropic prescribing in people with Intellectual Disability in primary care.
    Shankar R; Wilcock M
    PLoS One; 2018; 13(9):e0204178. PubMed ID: 30216381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An ethical dilemma: clinical psychologists prescribing psychotropic medications.
    Walker K
    Issues Ment Health Nurs; 2002; 23(1):17-29. PubMed ID: 11887607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mental illness, challenging behaviour, and psychotropic drug prescribing in people with intellectual disability: UK population based cohort study.
    Sheehan R; Hassiotis A; Walters K; Osborn D; Strydom A; Horsfall L
    BMJ; 2015 Sep; 351():h4326. PubMed ID: 26330451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiepileptic drugs with mood stabilizing properties and their relation with psychotropic drug use in institutionalized epilepsy patients with intellectual disability.
    Leunissen CL; de la Parra NM; Tan IY; Rentmeester TW; Vader CI; Veendrick-Meekes MJ; Aldenkamp AP
    Res Dev Disabil; 2011; 32(6):2660-8. PubMed ID: 21752594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prescribing cascades in older adults.
    Sternberg SA; Guy-Alfandary S; Rochon PA
    CMAJ; 2021 Feb; 193(6):E215. PubMed ID: 33558408
    [No Abstract]   [Full Text] [Related]  

  • 20. An Exploratory Study among Intellectual Disability Physicians on the Care and Coercion Act and the Use of Psychotropic Drugs for Challenging Behaviour.
    Bij de Weg JC; Honingh AK; Teeuw M; Sterkenburg PS
    Int J Environ Res Public Health; 2021 Sep; 18(19):. PubMed ID: 34639540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.